Tissue-specific inactivation of murine M6P/IGF2R

American Journal of Pathology

Volumn 162, Issue 1, 2003, Pages 321-328

  Wylie, Andrew A ^a   Pulford, David J ^a   McVie Wylie, Alison J ^a   Waterland, Robert A ^a   Evans, Heather K ^a   Chen, Yuan Tsong ^a   Nolan, Catherine M ^a,b   Orton, Terry C ^c   Jirtle, Randy L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B RECEPTOR;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CARCINOGENESIS; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL MODEL; FEMALE; FETUS GROWTH; GENE INACTIVATION; HEART MUSCLE; KNOCKOUT MOUSE; LETHALITY; LIVER; LYSOSOME; MALE; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SKELETAL MUSCLE; TISSUE SPECIFICITY;

EID: 0037219103     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63823-0     Document Type: Article

References (53)

1. Kornfeld S: Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu Rev Biochem 1992, 61:307-330
2. Jirtle RL. Mannose 6-phosphate receptors. Encyclopedia of Molecular Biology. Edited by Creidton TE. New York, Wiley-Liss, Inc., 1999, pp 1441-1447
3. Köster A, Saftig P, Matzner U, von Figura K, Peters C, Pohlmann R: Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO J 1993, 12:5219-5223
4. Ludwig T, Ovitt CE, Bauer U, Hollinshead M, Remmler J, Lobel P, Ruther U, Hoflack B: Targeted disruption of the mouse cation-dependent mannose 6-phosphate receptor results in partial missorting of multiple lysosomal enzymes. EMBO J 1993, 12:5225-5235
5. Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ: Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 1987, 329:301-307
6. Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC: Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Ce'l 2000, 103:491-500
7. Brown J, Esnouf RM, Jones MA, Linnell J, Harlos K, Hassan AB, Jones EY: Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur. EMBO J 2002, 21:1054-1062
8. Killian JK, Byrd JC, Jirtle JV, Munday BL, Stoskopf MK, MacDonald RG, Jirtle RL: M6P/IGF2R imprinting evolution in mammals. Mol Cell 2000, 5:707-716
9. Kirchhausen T: Single-handed recognition of a sorting traffic motif by the GGA proteins. Nat Struct Biol 2002, 9:241-244
10. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL: Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994, 8:2953-2963
11. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A: Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996, 177:517-535
12. Wang ZQ, Fung MR, Barlow DP, Wagner EF: Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 1994, 372:464-467
13. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD: Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture Nat Genet 2001, 27:153-154
14. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL: M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995, 11:447-449
15. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL: M6P/IGF2 receptor: A candidate breast tumor suppressor gene. Oncogene 1996. 12:2003-2009
16. Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL: M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 2000, 19:1572-1578
17. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou T-T, Shi Y-Q, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ: The insulin-like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours. Nat Genet 1996, 14:255-257
18. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ, Horii A: The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997, 57:1851-1854
19. Kang JX, Bell J, Beard RL, Chandraratna RA: Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ 1999, 10:591-600
20. O'Gorman DB, Costello M, Weiss J, Firth SM, Scott CD: Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells Cancer Res 1999, 59: 5692-5694
21. Souza RF, Wang S, Thakar M, Smolinski KN, Yin J, Zou TT, Kong D, Abraham JM, Toretsky JA, Meltzer SJ: Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 1999, 18:4063-4068
22. Clurman B, Groudine M: Tumour-suppressor genes: Killer in search of a motive? Nature 1997, 389:122-123
23. Barlow DP, Stöger R, Herrmann BG, Saito K, Schweifer N: The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 1991, 349:84-87
24. Nolan CM, Killian JK, Petitte JN, Jirtle RL: Imprint status of M6P/IGF2R and IGF2 in chickens. Dev Genes Evol 2001, 211:179-183
25. Killian JK, Nolan CM, Wylie AA, Li T, Vu TH. Hoffman AR, Jirtle RL. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet 2001, 10:1721-1728
26. De Souza AT, Yamada T, Mills JJ, Jirtle RL: Imprinted genes in liver carcinogenesis. EMBO J 1997, 11:60-67
27. Jirtle RL: Genomic imprinting and cancer. Exp Cell Res 1999, 248:18-24
28. O'Kane S, Ferguson MW: Transforming growth factor β and wound healing Int J Biochem Cell Biol 1997, 29:63-78
29. Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H, Schlossman SF, Morimoto C: Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci USA 2000, 97:8439-8444
30. Tarrago D, Aguilera I, Melero J, Wichmann I, Nunez-Roldan A, Sanchez B: Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies Immunology 1999, 98:652-662
31. Chorney MJ, Chorney K, Seese N, Owen MJ, Daniels J, McGuffin P, Thompson LA, Detterman DK, Benbow C, Lubinski D, Eley T, Plomin R: A quantitative trait locus associated with cognitive ability in children. Psychol Sci 1998, 9:159-166
32. Kuhn R, Schwenk F, Aguet M, Rajewsky K: Inducible gene targeting in mice Science 1995, 269:1427-1429
33. Killian JK, Jirtle RL: Genomic structure of the human M6P/IGF2 receptor. Mamm Genome 1999, 10:74-77
34. Hartshorn MA, Scott CD, Baxter RC: Immunofluorescent localization of type II insulin-like growth factor receptor in rat liver and hepatoma cells. J Endocrinol 1989, 121:221-227
35. Jirtle RL, Carr BI, Scott CD: Modulation of insulin-like growth factor/mannose-6-phosphate receptors and transforming growth factor-β1 during liver regeneration. J Biol Chem 1991, 266:22444-22450
36. Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, Edgemon KA, Marx SJ, Spiegel AM, Chandrasekharappa SC, Collins FS: Bi-directional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 2001, 30:259-263
37. Schwenk F, Baron U, Rajewsky K: A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 1995, 23:5080-5081
38. Lerchner W, Barlow DP: Paternal repression of the imprinted mouse Igf2r locus occurs during implantation and is stable in all tissues of the post-implantation mouse embryo. Mech Dev 1997, 61:141-149
39. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999, 274:305-315
40. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Bruning JC, Kahn CR, Clayton DA, Barsh GS, Thoren P, Larsson NG: Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 1999, 21:133-137
41. Yamada T, De Souza AT, Finkelstein S, Jirtle RL: Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997, 94:10351-10355
42. Postic C, Magnuson MA: DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000, 26:149-150
43. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R: Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994, 269:13779-13784
44. Raben N, Plotz P, Byrne BJ: Acid α-glucosidase deficiency (glycogenosis type II, Pompe disease) Curr Mol Med 2002, 2:145-166
45. Chen YT, Amalfitano A: Towards a molecular therapy for glycogen storage disease type II (Pompe disease). Mol Med Today 2000, 6:245-251
46. McCormick KM, Dahms NM, Lough J: Insulin-like growth factor-II/mannose-6-phosphate receptor expression during early heart development. Dev Dyn 1996, 207:195-203
47. Saris JJ, Derkx FH, Lamers JM, Saxena PR, Schalekamp MA, Danser AH: Cardiomyocytes bind and activate native human prorenin: Role of soluble mannose 6-phosphate receptors. Hypertension 2001, 37: 710-715
48. Brown NJ, Vaughan DE: Angiotensin-converting enzyme inhibitors. Circulation 1998, 97:1411-1420
49. Givertz MM: Manipulation of the renin-angiotensin system. Circulation 2001, 104:E14-E18
50. Vu TH, Hoffman AR: Comparative genomics sheds light on mechanisms of genomic imprinting. Genome Res 2000, 10:1660-1663
51. Couce ME, Weatherington AJ, McGinty JF: Expression of insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptor in the rat hippocampus: An in situ hybridization and immunocytochemical study Endocrinology 1992, 131:1636-1642
52. Kecha O, Brilot F, Martens H, Franchimont N, Renard C, Greimers R, Defresne MP, Winkler R, Geenen V: Involvement of insulin-like growth factors in early T cell development: A study using fetal thymic organ cultures. Endocrinology 2000, 141:1209-1217
53. Igney FH, Krammer PH: Immune escape of tumors: Apoptosis resistance and tumor counterattack. J Leukoc Biol 2002, 71:907-920